Association of plasma soluble CTLA-4 with lung function and GenePolymorphism in Chinese asthmatic children

International Archives of Allergy and Immunology

Volumn 152, Issue 2, 2010, Pages 113-121

  Chan, Iris H S ^a   Tang, Nelson L S ^a   Leung, Ting F ^a   Lam, Yvonne Y O ^a   Wong, Gary W K ^a   Wong, Chun K ^a   Lam, Christopher W K ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Aeroallergen; Asthma; CTLA 4; Genetic polymorphism; Immunoglobulin E

Indexed keywords

ALLERGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; AGE; ALLELE; ARTICLE; ASTHMA; ATOPY; CHILD; CHINESE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY;

EID: 72049091810     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265532     Document Type: Article

References (40)

1. Lafage-Pochitaloff M, Costello R, Couez D, et al: Human CD28 and CTLA4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 1990;31:198-201.
2. Alegre ML, Frauwirth KA, Thompson CB: T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001;1:220-228.
3. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997;15:389-392.
4. Koppelman GH, Stine OC, Xu J, et al: Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002;109:498-506.
5. Lee SY, Lee YH, Shin C, et al: Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002;122:171-176.
6. Howard TD, Postma DS, Koppelman GH, et al: Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002;110:743-751.
7. Jones G, Wu S, Jang N, Fulcher D, Hogan P, Stewart G: Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. Br J Dermatol 2006;154:467-471.
8. Hizawa N, Yamaguchi E, Jinushi E, Konno S, Kawakami Y, Nishimura M: Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B. J Allergy Clin Immunol 2001;108:74-79.
9. Yang KD, Liu CA, Chang JC, et al: Polymorphism of the immune-braking gene CTLA4 (+49) involved in gender discrepancy of serum total IgE levels and allergic disease. Clin Exp Allergy 2004;34:32-37.
10. Heinzmann A, Plesnar C, Kuehr J, Forster J, Deichmann KA: Common polymorphisms in the CTLA4 and CD28 genes at 2q33 are not associated with asthma or atopy. Eur J Immunogenet 2000;27:57-61. (Pubitemid 30213948)
11. Ueda H, Howson JM, Esposito L, et al: Association of T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-511.
12. Munthe-Kaas MC, Carlsen KH, Helms PJ, et al: CTLA-4 polymorphisms in allergy and asthma and the TH1/TH2 paradigm. J Allergy Clin Immunol 2004;114:280-287.
13. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-244.
14. Leung TF, Tang NL, Chan IH, Li AM, Ha G, Lam CW: A polymorphism in the coding region of IL-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001;31:1515-1521.
15. Ip MS, Karlberg EM, Karlberg JP, et al: Lung function reference values in Chinese children and adolescents in Hong Kong. I. Spirometric values and comparison with other populations. Am J Respir Crit Care Med 2000;162:424-429.
16. Chan IH, Leung TF, Tang NL, et al: Genegene interactions for asthma and plasma total IgE concentration in Chinese children. J Allerg y Clin Immunol 2006;117:127-133.
17. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
18. Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. La ncet 2002;360:1313-1322.
19. Shi HZ, Mo XY, Zhong XN: Soluble CTLA-4 in sera of patients with bronchial asthma. J Asthma 2005;42:133-139.
20. Qin XJ, Shi HZ, Qin SM, Kang LF, Huang CP, Zhong XN: Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics. Allergy 2005;60:774-779.
21. Miano JM: Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593.
22. Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA: CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum 2000;43:2219-2229.
23. Oaks MK, Hallett KM: Cutting edge: a soluble form of CTLA4 in patients with autoimmune thyroid disease. J Immunol 2000;164:5015-5018.
24. Liu MF, Wang CR, Chen PC, Fung LL: Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol 2003;57:568-572.
25. Wang XB, Kakoulidou M, Giscombe R, et al: Abnormal expression of CTLA4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 2002;130:224-232.
26. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ: A native soluble form of CTLA-4. Cell Immunol 2000;201:144-153.
27. Magistrelli G, Jeannin P, Herbault N, et al: A soluble form of CTLA4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999;29:3596-3602.
28. Carreno BM, Bennett F, Chau TA, et al: CTLA4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000;165:1352-1356.
29. Wiesch DG, Meyers DA, Bleecker ER: Genetics of asthma. J Allergy Clin Immunol 1999;104:895-901.
30. Szefler SJ, Apter A: Advances in pediatric and adult asthma. J Allergy Clin Immunol 2005;115:470-477.
31. Chan IH, Tang NL, Leung TF, et al: Study of gene-gene interactions for endophenotypic quantitative traits in Chinese asthmatic children. Allergy 2008;63:1031-1039.
32. Kline P: An Easy Guide to Factor Analysis. London, Routledge, 1994.
33. Pritchard JK, Stephens M, Donnelly P: Inference of population structure using multilocus genotype data. Genetics 2000;155:945-959.
34. Fok AO, Wong GW: What have we learnt from ISAAC phase III in the Asia-Pacific rim? Curr Opin Allergy Clin Immunol 2009;9:116-122.
35. Leung TF, Tang NL, Sung YM, et al: The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003;14:255-260.
36. van Dalen C, Harding E, Parkin J, Cheng S, Pearce N, Douwes J: Suitability of forced expiratory volume in 1 second/forced vital capacity vs. percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents. Arch Pediatr Adolesc Med 2008;162:1169-1174.
37. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA: Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004;170:426-432.
38. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997;15:389-392.
39. Lai CK, Douglass C, Ho SS, et al: Asthma epidemiology in the Far East. Clin Exp Allergy 1996;26:5-12.
40. Leung R, Ho P, Lam CW, Lai CK: Sensitisation to inhaled allergens as a risk factor for asthma and allergic disease in Chinese population. J Allergy Clin Immunol 1997;99:594-599.